U.S. appeals court declines J&J bid to stop generic Zytiga sales

A U.S. appeals court on Wednesday declined a request by Johnson & Johnson for an temporary restraining order blocking sales of generic versions of its cancer drug Zytiga from hitting the U.S. market.